Next Article in Journal
A Pharmacogenetic Panel-Based Prediction of the Clinical Outcomes in Elderly Patients with Coronary Artery Disease
Previous Article in Journal
Genetic Variation in CYP2D6, UGT1A4, SLC6A2 and SLCO1B1 Alters the Pharmacokinetics and Safety of Mirabegron
Previous Article in Special Issue
Validated LC-MS/MS Assay for the Quantitative Determination of Fenretinide in Plasma and Tumor and Its Application in a Pharmacokinetic Study in Mice of a Novel Oral Nanoformulation of Fenretinide
 
 
Editorial

Article Versions Notes

Pharmaceutics 2024, 16(8), 1078; https://doi.org/10.3390/pharmaceutics16081078 (registering DOI)
Action Date Notes Link
article xml file uploaded 17 August 2024 04:50 CEST Original file -
article xml uploaded. 17 August 2024 04:50 CEST Update https://www.mdpi.com/1999-4923/16/8/1078/xml
article pdf uploaded. 17 August 2024 04:50 CEST Version of Record https://www.mdpi.com/1999-4923/16/8/1078/pdf
article html file updated 17 August 2024 04:51 CEST Original file https://www.mdpi.com/1999-4923/16/8/1078/html
Back to TopTop